Adar1 Capital Management, LLC Lyra Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $539 Billion
- Q1 2025
A detailed history of Adar1 Capital Management, LLC transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 533,200 shares of LYRA stock, worth $58,652. This represents 0.01% of its overall portfolio holdings.
Number of Shares
533,200
Previous 533,200
-0.0%
Holding current value
$58,652
Previous $110 Million
38.81%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding LYRA
# of Institutions
56Shares Held
25MCall Options Held
56.6KPut Options Held
33.9K-
Perceptive Advisors LLC New York, NY12.8MShares$1.4 Million0.07% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$311,2970.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.77MShares$194,2140.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA1.39MShares$152,9140.08% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$116,3960.02% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $3.5M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...